162 related articles for article (PubMed ID: 3551160)
1. Randomized phase III trial of single versus multiple chemotherapeutic treatment following surgery and during radiotherapy for patients with anaplastic gliomas.
Mahaley MS; Whaley RA; Krigman MR; Bouldin TW; Bertsch L; Cush S
Surg Neurol; 1987 May; 27(5):430-2. PubMed ID: 3551160
[TBL] [Abstract][Full Text] [Related]
2. Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report.
Levin VA; Silver P; Hannigan J; Wara WM; Gutin PH; Davis RL; Wilson CB
Int J Radiat Oncol Biol Phys; 1990 Feb; 18(2):321-4. PubMed ID: 2154418
[TBL] [Abstract][Full Text] [Related]
3. Randomized trial of three chemotherapy regimens and two radiotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. Brain Tumor Cooperative Group Trial 8001.
Shapiro WR; Green SB; Burger PC; Mahaley MS; Selker RG; VanGilder JC; Robertson JT; Ransohoff J; Mealey J; Strike TA
J Neurosurg; 1989 Jul; 71(1):1-9. PubMed ID: 2661738
[TBL] [Abstract][Full Text] [Related]
4. Phase II study of 6-thioguanine, procarbazine, dibromodulcitol, lomustine, and vincristine chemotherapy with radiotherapy for treating malignant glioma in children.
Levin VA; Lamborn K; Wara W; Davis R; Edwards M; Rabbitt J; Malec M; Prados MD
Neuro Oncol; 2000 Jan; 2(1):22-8. PubMed ID: 11302250
[TBL] [Abstract][Full Text] [Related]
5. Phase III comparison of BCNU and the combination of procarbazine, CCNU, and vincristine administered after radiotherapy with hydroxyurea for malignant gliomas.
Levin VA; Wara WM; Davis RL; Vestnys P; Resser KJ; Yatsko K; Nutik S; Gutin PH; Wilson CB
J Neurosurg; 1985 Aug; 63(2):218-23. PubMed ID: 2991486
[TBL] [Abstract][Full Text] [Related]
6. Dibromodulcitol-based combined postoperative chemotherapy of malignant astrocytomas and glioblastomas.
Afra D; Kocsis B; Kerpel-Fronius S; Eckhardt S
J Neurooncol; 1986; 4(1):65-70. PubMed ID: 3746387
[TBL] [Abstract][Full Text] [Related]
7. [Chemotherapy in malignant gliomas].
Heuser K
Neurochirurgia (Stuttg); 1990 Oct; 33 Suppl 1():20-2. PubMed ID: 2293042
[TBL] [Abstract][Full Text] [Related]
8. Primary intracranial gliomas: clinical studies and treatment regimens of the Brain Tumor Research Center, University of California, San Francisco, 1977-1979.
Levin VA; Wilson CB; Vestnys PS
Cancer Treat Rep; 1981; 65 Suppl 2():83-8. PubMed ID: 7049363
[No Abstract] [Full Text] [Related]
9. NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide.
Wick W; Hartmann C; Engel C; Stoffels M; Felsberg J; Stockhammer F; Sabel MC; Koeppen S; Ketter R; Meyermann R; Rapp M; Meisner C; Kortmann RD; Pietsch T; Wiestler OD; Ernemann U; Bamberg M; Reifenberger G; von Deimling A; Weller M
J Clin Oncol; 2009 Dec; 27(35):5874-80. PubMed ID: 19901110
[TBL] [Abstract][Full Text] [Related]
10. A phase III comparison of BCNU, hydroxyurea, and radiation therapy to BCNU and radiation therapy for treatment of primary malignant gliomas.
Levin VA; Wilson CB; Davis R; Wara WM; Pischer TL; Irwin L
J Neurosurg; 1979 Oct; 51(4):526-32. PubMed ID: 225456
[No Abstract] [Full Text] [Related]
11. Combination of 6-thioguanine, procarbazine, lomustine, and hydroxyurea for patients with recurrent malignant gliomas.
Kyritsis AP; Yung WK; Jaeckle KA; Bruner J; Gleason MJ; Ictech SE; Flowers A; Levin VA
Neurosurgery; 1996 Nov; 39(5):921-6. PubMed ID: 8905746
[TBL] [Abstract][Full Text] [Related]
12. Radiation therapy and hydroxyurea followed by the combination of 6-thioguanine and BCNU for the treatment of primary malignant brain tumors.
Prados MD; Larson DA; Lamborn K; McDermott MW; Sneed PK; Wara WM; Chang SM; Mack EE; Krouwer HG; Chandler KL; Warnick RE; Davis RL; Rabbitt JE; Malec M; Levin VA; Gutin PH; Phillips TL; Wilson CB
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):57-63. PubMed ID: 9422558
[TBL] [Abstract][Full Text] [Related]
13. Randomized comparison of diaziquone and carmustine in the treatment of adults with anaplastic glioma.
Schold SC; Herndon JE; Burger PC; Halperin EC; Vick NA; Cairncross JG; Macdonald DR; Dropcho EJ; Morawetz R; Bigner DD
J Clin Oncol; 1993 Jan; 11(1):77-83. PubMed ID: 8418246
[TBL] [Abstract][Full Text] [Related]
14. Neuro-Oncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma.
Weller M; Müller B; Koch R; Bamberg M; Krauseneck P;
J Clin Oncol; 2003 Sep; 21(17):3276-84. PubMed ID: 12947063
[TBL] [Abstract][Full Text] [Related]
15. Postoperative radiotherapy and radiotherapy combined with CCNU chemotherapy for treatment of brain gliomas.
Trojanowski T; Peszyński J; Turowski K; Kamiński S; Gościński I; Reinfus M; Krzyszkowski T; Pyrich M; Bielawski A; Leszczyk C
J Neurooncol; 1988 Nov; 6(3):285-91. PubMed ID: 3066856
[TBL] [Abstract][Full Text] [Related]
16. [Chemotherapy of malignant glioma. Results of studies of the EORTC group of brain tumors].
Hildebrand JG
Rev Neurol (Paris); 1992; 148(6-7):435-40. PubMed ID: 1448663
[TBL] [Abstract][Full Text] [Related]
17. Interferon as adjuvant therapy with initial radiotherapy of patients with anaplastic gliomas.
Mahaley MS; Urso MB; Whaley RA; Williams TE; Guaspari A
J Neurosurg; 1984 Dec; 61(6):1069-71. PubMed ID: 6209367
[TBL] [Abstract][Full Text] [Related]
18. Randomized comparisons of radiotherapy and carmustine versus procarbazine versus dacarbazine for the treatment of malignant gliomas following surgery: a Southwest Oncology Group Study.
Eyre HJ; Eltringham JR; Gehan EA; Vogel FS; Al-Sarraf M; Talley RW; Costanzi JJ; Athens JW; Oishi N; Fletcher WS
Cancer Treat Rep; 1986 Sep; 70(9):1085-90. PubMed ID: 3017551
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant chemotherapy with carmustine and cisplatin for patients with malignant gliomas.
Yung WK; Janus TJ; Maor M; Feun LG
J Neurooncol; 1992 Feb; 12(2):131-5. PubMed ID: 1560258
[TBL] [Abstract][Full Text] [Related]
20. BCNU (NSC-409962) and procarbazine (NSC-77213) treatment for malignant brain tumors.
Levin VA; Crafts DC; Wilson CB; Schultz MJ; Boldrey EB; Enot KJ; Pischer TL; Seager M; Elashoff RM
Cancer Treat Rep; 1976 Mar; 60(3):243-9. PubMed ID: 177210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
